Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher I Li

Showing results (61-70 of 276) with videos related to

Pageof 28
Sort By:
Cancer Causes & Control : CCC|December 13, 2018
Reproductive and menopausal factors and risk of second primary breast cancer after in situ breast carcinomaMichelle L Baglia, Mei-Tzu C Tang, Kathleen E Malone, et al.
Cancer|July 11, 2006
Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladderJonathan L Wright, Michael P Porter, Christopher I Li, et al.
Breast Cancer Research and Treatment|August 21, 2012
Estrogen receptor, progesterone receptor, and HER2-neu expression in first primary breast cancers and risk of second primary contralateral breast cancerBabette Siebold Saltzman, Kathleen E Malone, Jean A McDougall, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 8, 2011
Relationship between menopausal symptoms and risk of postmenopausal breast cancerYi Huang, Kathleen E Malone, Kara L Cushing-Haugen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 27, 2010
Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening populationAmanda I Phipps, Christopher I Li, Karla Kerlikowske, et al.
Cancer Causes & Control : CCC|January 21, 2022
Association between antidepressant use and second breast cancer event after ductal carcinoma in situ diagnosis: a nested case-control studyElizabeth T Mansi, Kathleen E Malone, Mei-Tzu Tang, et al.
Clinical Chemistry|March 23, 2016
Early-Phase Studies of Biomarkers: What Target Sensitivity and Specificity Values Might Confer Clinical Utility?Margaret S Pepe, Holly Janes, Christopher I Li, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 18, 2008
Relationship between histamine2-receptor antagonist medications and risk of invasive breast cancerRobert W Mathes, Kathleen E Malone, Janet R Daling, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 31, 2008
Body size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal womenAmanda I Phipps, Kathleen E Malone, Peggy L Porter, et al.
Cancer|August 30, 2008
Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancerAmanda I Phipps, Kathleen E Malone, Peggy L Porter, et al.
Pageof 28

Showing results (61-70 of 276) with videos related to

Sort By:
Pageof 28
Cancer Causes & Control : CCC|December 13, 2018
Reproductive and menopausal factors and risk of second primary breast cancer after in situ breast carcinomaMichelle L Baglia, Mei-Tzu C Tang, Kathleen E Malone, et al.
Cancer|July 11, 2006
Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladderJonathan L Wright, Michael P Porter, Christopher I Li, et al.
Breast Cancer Research and Treatment|August 21, 2012
Estrogen receptor, progesterone receptor, and HER2-neu expression in first primary breast cancers and risk of second primary contralateral breast cancerBabette Siebold Saltzman, Kathleen E Malone, Jean A McDougall, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 8, 2011
Relationship between menopausal symptoms and risk of postmenopausal breast cancerYi Huang, Kathleen E Malone, Kara L Cushing-Haugen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 27, 2010
Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening populationAmanda I Phipps, Christopher I Li, Karla Kerlikowske, et al.
Cancer Causes & Control : CCC|January 21, 2022
Association between antidepressant use and second breast cancer event after ductal carcinoma in situ diagnosis: a nested case-control studyElizabeth T Mansi, Kathleen E Malone, Mei-Tzu Tang, et al.
Clinical Chemistry|March 23, 2016
Early-Phase Studies of Biomarkers: What Target Sensitivity and Specificity Values Might Confer Clinical Utility?Margaret S Pepe, Holly Janes, Christopher I Li, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 18, 2008
Relationship between histamine2-receptor antagonist medications and risk of invasive breast cancerRobert W Mathes, Kathleen E Malone, Janet R Daling, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 31, 2008
Body size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal womenAmanda I Phipps, Kathleen E Malone, Peggy L Porter, et al.
Cancer|August 30, 2008
Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancerAmanda I Phipps, Kathleen E Malone, Peggy L Porter, et al.
Pageof 28